EFAI RTSuite CT HN-Segmentation System

by Ever Fortune.AI Co., Ltd.  · Based in Taiwan → — Revolutionize the healthcare industry with cutting-edge digital solutions for improved patient outcomes.
Oncology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

The EFAI RTSuite CT HN-Segmentation System is a standalone software device designed to assist trained radiation oncology professionals, including radiation oncologists, medical physicists, and dosimetrists, during their clinical workflows of radiation therapy treatment planning. It automatically delineates head-and-neck organs-at-risk (OARs) on non-contrast CT images. The system receives CT images in DICOM format as input and automatically generates the contours of OARs, which are stored in DICOM format and in RTSTRUCT modality. This auto-contouring of OARs is intended to facilitate radiation therapy workflows and help reduce the time of treatment planning. The device does not offer a user interface and must be used in conjunction with a DICOM-compliant treatment planning system to review and edit the generated results. It is an adjunct tool and is not intended to be used for decision-making, to detect lesions, or to replace a clinician’s judgment and manual contouring of normal organs on CT. Clinicians must not use the software-generated output alone without review as the primary interpretation.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automatic delineation of head-and-neck organs-at-risk (OARs) on CT images
  • Facilitates radiation therapy workflows
  • Receives CT images in DICOM format
  • Generates contours in DICOM RTSTRUCT modality
  • Utilizes deep-learning algorithms for contour generation
  • Compatible with DICOM-compliant treatment planning systems for review and editing
  • Supports multi-modality image registration (CT, MRI, PET)
  • Intended for use by trained radiation oncology professionals
  • Designed as an adjunct tool, not for primary diagnosis or decision-making
  • Recommended for deployment in a local network with hospital-grade IT systems

Use Cases

  • Assisting in radiation therapy treatment planning
  • Automating the contouring of organs-at-risk (OARs)
  • Improving efficiency in radiotherapy workflow
  • Reducing the time required for treatment planning
  • Providing initial contours for head and neck regions on non-contrast CT images

What Physicians Need to Know

Key Capabilities
Automatically delineates head-and-neck organs-at-risk (OARs) on CT images for radiation oncology treatment planning. The system uses deep-learning algorithms to generate contours, stored in DICOM format and RTSTRUCT modality. Newer versions can delineate up to 80 critical organ structures across multiple regions including head, neck, male pelvis, thorax, and abdomen, supporting both CT and MR imaging.
Clinical Utility
Assists radiation oncology professionals (radiation oncologists, medical physicists, dosimetrists) by providing initial OAR contours, aiming to significantly reduce manual contouring time and improve workflow efficiency. It also seeks to enhance contour consistency and accuracy, and decrease inter-observer variability. The tool is an adjunct and requires clinician review and editing of generated contours.
Integration Options
Receives input CT images in DICOM format and outputs results as DICOM-RT Structure Sets to a user-configurable target node. It requires DICOM 3.0 compliance and must be used with a DICOM-compliant treatment planning system (TPS) for review and editing. The system is designed for deployment within a local hospital network on a specialized server for deep learning processing.
Compliance Status
Holds a TFDA medical equipment license (DOH-MD-No. 007449) and USFDA Premarket Notification, 510(k), No. K220264, classifying it as a Class II regulatory device.
Pricing Model
Specific pricing information for the EFAI RTSuite CT HN-Segmentation System is not publicly disclosed. Typically, similar AI segmentation tools in healthcare may utilize tiered subscription models or per-use pricing.
User Experience
The EFAI RTSuite CT HN-Segmentation System itself operates as a backend process without a direct user interface; it automatically processes data once routed. User interaction for review and editing occurs within the integrated DICOM-compliant treatment planning system.
Support Quality
Details on specific support quality are not publicly available. The manufacturer operates the system's configurations, implying direct manufacturer involvement in setup and maintenance.
Implementation Complexity
The system is standalone software requiring installation on a specialized server within a hospital's local network. Manufacturer involvement is required for initial configuration of network settings and output management. The technology was developed and validated in collaboration with China Medical University Hospital.
Evidence Base
The system is built upon deep-learning algorithms, with models strengthened by hybrid 2D/3D deep learning architecture and visual transformer models to improve segmentation accuracy. Clinical validation has shown good geometric accuracy and minimal dosimetric impact on treatment plans, with significant time savings compared to manual contouring (e.g., 22 minutes vs. 69 minutes for brain OARs in one study). The technology was developed and validated by China Medical University Hospital.
Physician Tip

This AI tool is designed to be a powerful assistant, not a replacement for clinical judgment. Always thoroughly review and, if necessary, manually adjust the AI-generated contours within your treatment planning system. Leverage its speed for routine cases to free up time for more complex planning and patient-specific considerations. While initially focused on head and neck OARs, be aware of its expanding capabilities to other anatomical regions and imaging modalities.

The EFAI RTSuite CT HN-Segmentation System operates as a backend service. Ensure your existing treatment planning system is DICOM 3.0 compliant for seamless input and output of image data and RT Structure Sets. Plan for dedicated server infrastructure within your local network to host the deep learning processing, with manufacturer support for initial setup and configuration.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentRecommended to be deployed in a local network with an existing hospital-grade IT system, installed on a specialized server supporting deep learning processing.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The EFAI RTSuite CT HN-Segmentation System (K220264) received FDA 510(k) clearance on April 28, 2022. It is classified as a Class II medical device under regulation 21 CFR 892.2050, Medical Image Management and Processing System, with product code QKB.

Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

The EFAI RTSuite CT HN-Segmentation System is an AI-powered standalone software designed to automate the delineation of head-and-neck organs-at-risk (OARs) on CT images for radiation oncology treatment planning. This system aims to streamline radiation therapy workflows by reducing the time-consuming manual contouring process. It has received regulatory approvals from both Taiwan's TFDA and the US FDA.

Overall: Positive

Strengths

  • Automates the delineation of head-and-neck organs-at-risk (OARs) on CT images.
  • Facilitates radiation therapy workflows and reduces treatment planning time.
  • Aims to improve contour consistency and accuracy, and decrease inter-observer variability.
  • Utilizes deep-learning algorithms for contour generation.
  • Integrates with DICOM-compliant treatment planning systems for review and editing.
  • Has received TFDA and US FDA approvals.

Limitations

  • Not intended for decision-making or lesion detection; it is an adjunct tool.
  • Requires review and potential manual correction by trained radiation oncology professionals.
  • The software does not offer a user interface and must be used with a DICOM-compliant treatment planning system.
  • General challenges with AI auto-segmentation include the need for model validation, standardization, and external validation in diverse patient populations.
  • No specific negative reviews from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found for this particular product in the search results.

Based on reviews from: Healthcare+ B2B, accessdata.fda.gov, FDA.report, China Medical University Hospital, Ever Fortune.AI, PMC, TechNewsWorld

Last updated: 2026-07-19

Ratings & Reviews

Rate EFAI RTSuite CT HN-Segmentation System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for EFAI RTSuite CT HN-Segmentation System.

Loading videos...

View all on YouTube

Frequently Asked Questions

The EFAI RTSuite CT HN-Segmentation System is a standalone software designed to receive non-contrast CT images in DICOM format and automatically generate initial contours of head-and-neck organs-at-risk (OARs) in RTSTRUCT modality. It must be used in conjunction with a DICOM-compliant treatment planning system (TPS) for review and editing, as it does not offer its own user interface. This integration aims to streamline the initial contouring process, allowing trained radiation oncology professionals to focus on critical review and adjustments.
The EFAI RTSuite CT HN-Segmentation System is intended as an adjunct tool to assist trained professionals and is not meant to replace a clinician's judgment, manual contouring, or for decision-making or lesion detection. Clinicians must always review and edit the software-generated output as the primary interpretation. Its performance can also be influenced by patient-specific anatomical variations, disease burden, and the characteristics of the training data.
The EFAI RTSuite CT HN-Segmentation System has received FDA 510(k) clearance (K220264) and is classified as a Class II medical device under 21 CFR 892.2050, pertaining to Medical Image Management and Processing Systems. It is also important to note that devices like this will need to demonstrate compliance with the more stringent requirements of the EU AI Act, which became effective on August 1, 2024, with a transitionary period for compliance until August 2, 2026.
Several other AI-driven auto-segmentation systems are available, including MVision AI, Varian Ethos, RayStation (with AI planning optimization), and GE HealthCare's iRT with MR Contour DL. While many systems offer broad OAR segmentation, EFAI RTSuite specifically focuses on head and neck OARs on CT images, aiming to provide efficient and consistent initial contours for this complex anatomical region. The choice often depends on specific departmental needs, existing TPS compatibility, and the range of anatomical sites covered.
Specific pricing information for the EFAI RTSuite CT HN-Segmentation System is not publicly available, as is common for specialized medical software, and typically involves direct negotiation with the vendor. Cost considerations would generally include the software license, necessary hardware (a specialized server supporting deep learning processing), integration services with existing DICOM-compliant treatment planning systems, and ongoing maintenance and support fees. It is recommended to contact Ever Fortune.AI Co., Ltd. directly for a detailed quotation.
The system utilizes deep-learning algorithms to generate contours, and studies on similar AI auto-contouring systems have demonstrated significant reductions in contouring time and improved consistency and accuracy compared to manual methods. For instance, some studies indicate that AI-generated contours are clinically usable with minimal or no edits in a high percentage of cases, thereby enhancing workflow efficiency in radiation therapy planning.
The system requires non-contrast CT images as input, adhering to the DICOM standard, and generates output in DICOM RTSTRUCT format. It is designed for deployment within a local network with an existing hospital-grade IT system and necessitates installation on a specialized server capable of supporting deep learning processing. Compatibility with your specific DICOM-compliant treatment planning system is essential for reviewing and editing the generated contours.

Related Tools

Visiopharm AI-driven Precision Pathology
Visiopharm
Oncology AI
Visiopharm provides AI-driven precision pathology software for research and diagnostics, offering image analysis applications for metastasis detection and biomarker evaluation.
DeepHeme
Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley)
Lab & Diagnostics
DeepHeme is an AI tool developed by Memorial Sloan Kettering Cancer Center, UCSF, and UC Berkeley that automates the counting and classification of blood and bone marrow cells to assist in the diagnosis of blood cancers, reducing manual review time and achieving expert-level accuracy.
ScreenPoint Medical
ScreenPoint Medical
Clinical Decision Support & Reference
ScreenPoint Medical offers Transpara, an AI-powered solution for breast cancer detection and diagnosis in mammography and digital breast tomosynthesis, designed to assist radiologists.
INIFY Prostate
ContextVision
Clinical Decision Support & Reference
INIFY Prostate is an AI-based decision support tool that accurately outlines suspicious prostate cancer areas in digitalized prostate biopsy samples.
Cartesion Prime (PCD-1000A/3) V10.21
Canon Medical Systems USA, Inc.
Clinical Decision Support & Reference
The Cartesion Prime (PCD-1000A/3) V10.21 is a premium, air-cooled digital PET/CT scanner from Canon Medical Systems, featuring AI-assisted deep learning reconstruction (AiCE) for superior image quality, faster scans, and reduced dose.
DERM (by Skin Analytics)
Skin Analytics
Clinical Decision Support & Reference
DERM is an AI as a Medical Device (AIaMD) with Class III CE mark that assesses dermoscopic images of skin lesions to provide a suspected diagnosis and referral recommendation, aiming to triage patients and reduce waiting times for skin cancer assessment.

See all Oncology AI tools →

More from Ever Fortune. AI

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Ever Fortune.AI Co.
Radiology & Imaging AI
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is an FDA-cleared AI software that quantifies bone age from left-hand X-rays for pediatric patients (2-16 years old), assisting radiologists in diagnosis and workflow efficiency.
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM
Ever Fortune.AI
Cardiology AI
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM is an AI-powered radiological computer-assisted triage and notification software that rapidly detects features suggestive of acute aortic dissection or intramural hematoma from CTA images, alerting PACS/RIS workstations for earlier review.
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)
Ever Fortune.AI
Radiology & Imaging AI
AI-powered computer-aided triage and notification software for assessing malpositioned endotracheal tubes on chest X-rays, designed to enhance patient safety and improve clinical outcomes through rapid alerts.
EFAI ChestSuite XR Pleural Effusion Assessment System
Ever Fortune.AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.